Literature DB >> 2068115

Purification of parathyroid hypertensive factor from plasma of spontaneously hypertensive rats.

C G Benishin1, R Z Lewanczuk, P K Pang.   

Abstract

Parathyroid hypertensive factor (PHF) is a newly described hypertensive factor that may be related to elevation of blood pressure in 30-40% of North American essential hypertensive patients. PHF is also found in several animal models of hypertension, including spontaneously hypertensive rats, and deoxycorticosterone acetate salt hypertensive rats. Plasma collected from spontaneously hypertensive rats (SHR) was used in the present study for purification of PHF. Plasma was dialyzed at a molecular mass cutoff of 1 kDa, and then ultrafiltered at a molecular mass cutoff of 5 kDa. PHF activity, as determined by bioassay (characteristic delayed hypertensive response in normotensive rat) was retained in the fraction that was greater than 1 kDa and less than 5 kDa. Dialyzed and ultrafiltered SHR plasma was fractionated by molecular-exclusion chromatography, either with Bio-Gel P-6 liquid chromatography, or TSK 2000 SW HPLC. The biological activity was detected in a discrete region corresponding to a molecular mass of 2.5-3 kDa. When the molecular-exclusion fraction was subsequently fractionated by reverse-phase HPLC, biological activity was located in a single discrete peak, which did not occur in plasma from normotensive rats prepared in a similar manner. The biologically active fraction of PHF was inactivated by trypsin; this and its UV spectrum indicate the presence of a peptide structure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068115      PMCID: PMC52085          DOI: 10.1073/pnas.88.14.6372

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Effects of spontaneously hypertensive rat plasma on blood pressure and tail artery calcium uptake in normotensive rats.

Authors:  R Z Lewanczuk; J Wang; Z R Zhang; P K Pang
Journal:  Am J Hypertens       Date:  1989-01       Impact factor: 2.689

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

3.  Effect of plasma from hypertensive subjects on Ca2+ transport in permeabilized human neutrophils.

Authors:  W Zidek; A Sachinidis; C Spieker; W Storkebaum
Journal:  Clin Sci (Lond)       Date:  1988-01       Impact factor: 6.124

4.  A novel human plasma factor(s) capable of mobilizing intracellular Ca2+ in cultured rat vascular smooth muscle cells.

Authors:  H Yoshimi; Y Hirata; S Takata; Y Takagi; Y Fukuda; M Kuramochi; T Omae
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

5.  Assay of a circulating sodium pump inhibitor in patients with essential hypertension and normotensive subjects.

Authors:  T Umeda; S Naomi; J Inoue; M Ohno; F Miura; S Hamasaki; T Iwaoka; T Sato
Journal:  Clin Exp Hypertens A       Date:  1987

6.  Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism.

Authors:  L M Resnick; F B Müller; J H Laragh
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

7.  Parathyroidectomy significantly decreases hypertension in spontaneously hypertensive and deoxycorticosterone plus saline treated rats.

Authors:  A Gairard; A Berthelot; R Schleiffer; F Pernot
Journal:  Can J Physiol Pharmacol       Date:  1982-02       Impact factor: 2.273

8.  Structure activity relationship of parathyroid hormone: separation of the hypotensive and the hypercalcemic properties.

Authors:  P K Pang; M C Yang; H T Keutmann; A D Kenny
Journal:  Endocrinology       Date:  1983-01       Impact factor: 4.736

9.  The association of intakes of vitamin D and calcium with blood pressure among women.

Authors:  M R Sowers; R B Wallace; J H Lemke
Journal:  Am J Clin Nutr       Date:  1985-07       Impact factor: 7.045

10.  Partial purification of a hypertensive substance from rat erythrocytes.

Authors:  W D McCumbee; G L Wright
Journal:  Can J Physiol Pharmacol       Date:  1985-10       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.